|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Avenue Therapeutics, Inc. (ATXI) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
16,750,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Avenue Therapeutics is a pharmaceutical company that develop and commercialize its product principally for use in the acute/intensive care hospital setting. Co.'s product candidate is intravenous (IV) Tramadol, for the treatment of post-operative acute pain. Tramadol, a synthetic dual-acting opioid, is a centrally acting analgesic with weak opioid agonist properties. It also works via the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. Co. has completed a pharmacokinetic study for IV Tramadol in healthy volunteers. Co. also has initiated a Phase 3 development program of IV Tramadol for the management of post-operative pain.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
767,085 |
Total Buy Value |
$0 |
$0 |
$0 |
$552,301 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
617,000 |
1,005,888 |
Total Sell Value |
$0 |
$0 |
$86,560 |
$3,086,442 |
Total People Sold |
0 |
0 |
1 |
2 |
Total Sell Transactions |
0 |
0 |
2 |
3 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Coronado Biosciences Inc |
10% Owner |
|
2024-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
413,507 |
3,547,393 |
|
- |
|
Coronado Biosciences Inc |
10% Owner |
|
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,101,496 |
3,133,886 |
|
- |
|
Davidow Robert L |
10% Owner |
|
2023-12-11 |
4 |
S |
$0.14 |
$49,600 |
I/I |
(353,000) |
80,000 |
|
- |
|
Davidow Robert L |
10% Owner |
|
2023-12-11 |
4 |
S |
$0.14 |
$36,960 |
D/D |
(264,000) |
681,000 |
|
- |
|
Davidow Robert L |
10% Owner |
|
2023-10-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
981,800 |
|
- |
|
Davidow Robert L |
10% Owner |
|
2023-10-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
945,000 |
|
- |
|
Coronado Biosciences Inc |
10% Owner |
|
2023-09-08 |
4 |
B |
$0.72 |
$301,255 |
D/D |
418,410 |
1,032,390 |
2.45 |
- |
|
Rosenwald Lindsay A Md |
Director |
|
2023-09-08 |
4 |
B |
$0.72 |
$251,046 |
D/D |
348,675 |
354,318 |
2.39 |
- |
|
Coronado Biosciences Inc |
10% Owner |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
231,316 |
561,561 |
|
- |
|
Coronado Biosciences Inc |
10% Owner |
|
2022-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
90,909 |
330,245 |
|
- |
|
Invagen Pharmaceuticals, Inc. |
10% Owner |
|
2022-10-11 |
4 |
S |
$7.71 |
$2,999,882 |
D/D |
(388,888) |
0 |
|
- |
|
Kranzler Jay D |
Director |
|
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
69,020 |
133,683 |
|
- |
|
Herskowitz Neil |
Director |
|
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
69,020 |
183,744 |
|
- |
|
Oltmans Curtis Gale |
Director |
|
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
49,020 |
49,020 |
|
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
100,505 |
165,757 |
|
- |
|
Lu Lucy |
President, CEO |
|
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
411,616 |
748,949 |
|
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2021-09-15 |
4 |
S |
$1.62 |
$11,599 |
D/D |
(7,160) |
65,252 |
|
- |
|
Herskowitz Neil |
Director |
|
2021-05-06 |
4 |
B |
$3.99 |
$9,975 |
D/D |
2,500 |
134,724 |
2.39 |
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2020-08-20 |
4 |
S |
$12.13 |
$46,579 |
D/D |
(3,840) |
57,412 |
|
- |
|
Kranzler Jay D |
Director |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
84,663 |
|
- |
|
Herskowitz Neil |
Director |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
132,224 |
|
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2020-03-10 |
4 |
B |
$7.94 |
$14,999 |
D/D |
1,889 |
61,252 |
2.74 |
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2020-03-09 |
4 |
B |
$7.97 |
$11,983 |
D/D |
1,500 |
59,363 |
2.74 |
- |
|
Herskowitz Neil |
Director |
|
2020-02-27 |
4 |
B |
$8.20 |
$19,680 |
D/D |
2,400 |
122,224 |
2.39 |
- |
|
Herskowitz Neil |
Director |
|
2020-02-26 |
4 |
B |
$8.73 |
$1,406 |
D/D |
161 |
119,824 |
2.31 |
- |
|
85 Records found
|
|
Page 1 of 4 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|